Bicara Therapeutics BCAX Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bicara Therapeutics's operating income?
- Bicara Therapeutics (BCAX) reported operating income of -$60.24M in Q1 2026.
- How has Bicara Therapeutics's operating income changed year-over-year?
- Bicara Therapeutics's operating income decreased by 44.2% year-over-year, from -$41.79M to -$60.24M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.